Answers are grounded in this paper and cite their sources.
Implication for health policy/practice/research/medical education: Adriamycin is an anticancer agent with broad-spectrum efficacy against tumors.However, chemotherapy-induced renal toxicity constraints clinical efficacy of cancer treatment.The nephropathy of adriamycin is detected by podocyte damage and foot process effacement, which followed by glomerulosclerosis and inflammation in the tubulointerstitial area and fibrosis.
No takes yet. Share an insight, caveat, or question.
Mahnaz Momenzadeh (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: